¢£ Â軰ɱ¡TOP¥Ú¡¼¥¸

¾®»ù²Ê


2024ǯ10·î¸½ºß
³°ÍèôÅö°åɽ ¥Õ¥í¥¢°ÆÆâ¤Ø Á°¤ËÌá¤ë

photo

¿ÇÎÅÉôĹ¡§¾¡¾Â¡¡½Óͺ

¿ÇÎÅ¥¹¥¿¥Ã¥Õ ¿ÇÎÅ¥Õ¥í¥¢
¿ÇÎÅÉôĹ ¾¡¾Â¡¡½Óͺ
°å»Õ¿ô ¾ï¶Ð9̾¡¢Èó¾ï¶Ð2̾

¥¹¥¿¥Ã¥Õ


¿¦Ì¾ °å»Õ̾ ´ǯÅÙ ¿¦°Ì ÀìÌçÎÎ°è »ñ³Ê
¿ÇÎÅÉôĹ ¾¡¾Â¡¡½Óͺ ¾¼ÏÂ60ǯ ¶µ¼ø ¾®»ù²Ê°ìÈÌ
¥¢¥ì¥ë¥®¡¼¼À´µ
¾®»ù²ÊÀìÌç°å¡¦»ØƳ°å
ÆüËÜ¥¢¥ì¥ë¥®¡¼³Ø²ñÀìÌç°å¡¦»ØƳ°å
¿ÇÎÅ°å°÷ üâÌÚ¡¡·ò Ê¿À®14ǯ ½õ¶µ ¾®»ù²Ê°ìÈÌ
½Û´Ä´ï¼À´µ
¾®»ù²ÊÀìÌç°å
¿ÇÎÅ°å°÷ ã·Æ£¡¡¿¿´õ Ê¿À®20ǯ ½õ¶µ ¾®»ù²Ê°ìÈÌ
ÆâʬÈç¼À´µ
¾®»ù²ÊÀìÌç°å
¿ÇÎÅ°å°÷ ÁêÎÉ¡¡Ä¹½Ó Ê¿À®22ǯ ½õ¶µ ¾®»ù²Ê°ìÈÌ
¥¢¥ì¥ë¥®¡¼¼À´µ
¾®»ù²ÊÀìÌç°å
ÆüËÜ¥¢¥ì¥ë¥®¡¼³Ø²ñÀìÌç°å
¿ÇÎÅ°å°÷ ±ü°æ¡¡°ìÀ® Ê¿À®27ǯ ½õ¶µ ¾®»ù²Ê°ìÈÌ
¥¢¥ì¥ë¥®¡¼¼À´µ
¾®»ù²ÊÀìÌç°å
¿ÇÎÅ°å°÷ À®瀨¡¡È»¿Í Ê¿À®29ǯ ½õ¶µ ¾®»ù²Ê°ìÈÌ
ÀèÅ·Âå¼Õ°Û¾ï¼À´µ
¾®»ù²ÊÀìÌç°å
¥ì¥¸¥Ç¥ó¥È ¿¹Â¿¡¡ÌÀÆü¹á ÎáÏÂ3ǯ ¥ì¥¸¥Ç¥ó¥È ¾®»ù²Ê°ìÈÌ
¥ì¥¸¥Ç¥ó¥È Æ£ÅÄ¡¡Í³¸« ÎáÏÂ3ǯ ¥ì¥¸¥Ç¥ó¥È ¾®»ù²Ê°ìÈÌ
¥ì¥¸¥Ç¥ó¥È ¿å±Û¡¡½ß ÎáÏÂ4ǯ ¥ì¥¸¥Ç¥ó¥È ¾®»ù²Ê°ìÈÌ
¿ÇÎÅ°å°÷ ÀÄÅÄ¡¡ÌÀ»Ò Ê¿À®12ǯ Èó¾ï¶Ð ¾®»ù²Ê°ìÈÌ
¥¢¥ì¥ë¥®¡¼¼À´µ
¾®»ù²ÊÀìÌç°å
ÆüËÜ¥¢¥ì¥ë¥®¡¼³Ø²ñÀìÌç°å
¿ÇÎÅ°å°÷ ÎëÌÚ¡¡Î¼Ê¿ Ê¿À®23ǯ Èó¾ï¶Ð ¾®»ù²Ê°ìÈÌ
¥¢¥ì¥ë¥®¡¼¼À´µ
¾®»ù²ÊÀìÌç°å
ÆüËÜ¥¢¥ì¥ë¥®¡¼³Ø²ñÀìÌç°å
Î×¾²¿´Íý»Î Á°ÅÄ¡¡·ÃΤ Î×¾²¿´Íý³Ø¡Êȯ㡦¿´Íý¸¡ºº¡¤°é»ùÁêÃÌ¡¤¥×¥ì¥¤¥»¥é¥Ô¡¼¡¤¥«¥¦¥ó¥»¥ê¥ó¥°¡Ë Î×¾²¿´Íý»Î
¸øǧ¿´Íý»Õ

¿ÇÎÅÆâÍÆ¡¦ÀìÌçʬÌî


³°Íè¿ÇÎÅ °ìÈ̳°Íè¡Ê·î¡ÁÅÚ¡¢³°Íè¼õÉÕ»þ´Ö¡§ 8»þ¡Á11»þ30ʬ¡Ë

°ìÈ̳°Íè¤Ï¡¢È¯Ç®¡¢É¡¿å¡¢³±¡¢¤Ï¤­¤±¡¦ÓÒÅÇ¡¢¿©Íߤ¬¤Ê¤¤¡¢Ä«µ¯¤­¤é¤ì¤Ê¤¤¡¢²¼Î¡¡¢¤á¤Þ¤¤¡¢ÄˤߡÊƬ¡¦¶»¡¦Ê¢¡Ë¤Ê¤É¤Î°ìÈÌŪ¤Ê¾É¾õ¤ò´Þ¤á¡¢¤É¤Î¤è¤¦¤Êɵ¤¤ËÂФ·¤Æ¤âÃúÇ«¤Ê¿ÇÎŤò¿´¤¬¤±¤Æ¤¤¤Þ¤¹¡£³§¤µ¤Þ¤Î¤ªÏä˼ª¤ò·¹¤±¡¢½½Ê¬¤Ê»þ´Ö¤ò¤«¤±¤ÆÂбþ¤µ¤»¤Æ夭¤Þ¤¹¡£
µÞ´µ¡¦¿·´µ¤ÎÊý¤â¿ï»þ¿Ç»¡¤·¤Æ¤ª¤ê¤Þ¤¹¡£
¤Þ¤¿¡¢¸ÀÍÕ¤¬ÃÙ¤¤¡¢Íî¤ÁÃ夭¤¬¤Ê¤¤¡¢Í§Ã£¤È¾å¼ê¤¯¤¤¤«¤Ê¤¤¡¢ÊÙ¶¯¤Ë¤Ä¤¤¤Æ¤¤¤±¤Ê¤¤¡¢³Ø¹»¤Ë¹Ô¤±¤Ê¤¤¡¢¤ä¤ëµ¤¤¬½Ð¤Ê¤¤¡¢¥¤¥é¥¤¥é¤·¤Æ¤¤¤ë¤Ê¤É¡¢¾®»ù¤ÎȯãÁêÃÌ¡¦¤³¤³¤í¤Î½ôÌäÂê¤Ë¤Ä¤¤¤Æ¡¢ÅÚÍËÆü¤ò´Þ¤á¤¿½µ5Æü¡¢Î×¾²¿´Íý»Î¤¬Âбþ¤·¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç¡¢¤ªµ¤·Ú¤Ë°å»Õ¤Þ¤Ç¤´ÁêÃ̤¯¤À¤µ¤¤¡£

¡öͽÌó¤Ê¤·¤Ç¿Ç»¡Ãפ·¤Þ¤¹¡£½é¿Ç¼õÉդǾ®»ù²Ê¤ò´õ˾¤·¤Æ¤¯¤À¤µ¤¤¡£¾°¡¢¾Ò²ð¾õ¤Ê¤É¤ò¤ª»ý¤Á¤Ç¤Ê¤¤¾ì¹ç¤Ï¡¢½é¿Ç»þÁªÄêÎÅÍÜÈñ¤òÊÌÅÓ¤ª»Ùʧ夭¤Þ¤¹¡£
¡öÍËÆü¤Ë¤è¤ê°ìÈ̳°ÍèôÅö°å¤ÎÀìÌçʬÌ°Û¤Ê¤ê¤Þ¤¹¡£ÆÃÄê¤ÎÀìÌçʬÌî¤Ë´Ø¤·¤Æ¤Î¿ÇÎŤò¤´´õ˾¤µ¤ì¤ë¾ì¹ç¤Ë¤Ï¡¢»öÁ°¤Ë¼õ¿ÇÆü¤ò¤´³Îǧ²¼¤µ¤¤¡£
¡ö¼õÉÕ»þ´Ö³°¤Ë¼õ¿Ç¤µ¤ì¤¿¾ì¹ç¤Ë¤Ï¡¢»þ´Ö³°¿ÇÎÅ¡Ê°å»Õ¸òÂåÀ©¡Ë¤È¤Ê¤ë¤¿¤á¡¢³ÆÀìÌçʬÌî¤Ë´Ø¤ï¤ë¤´ÁêÃ̤ϤǤ­¤Þ¤»¤ó¡£ÁêÃ̤ò´õ˾¤µ¤ì¤ë¾ì¹ç¤Ï¡¢¿Ç»¡°å¤Ë¤è¤ê°ìÈ̳°Íè¤Þ¤¿¤Ï³ÆÀìÌçʬÌî¤Î³°Íè¤ËͽÌó¤ò¤ª¤È¤ê¤µ¤»¤Æ夭¤Þ¤¹¡£¤´ÉÔÊؤò¤ª¤«¤±¤·¤Þ¤¹¤¬¡¢²¿Â´¤´Î»¾µ¤¯¤À¤µ¤¤¡£

ÀìÌç³°Íè¤Ê¤É¡§¸á¸å

ÀìÌç³°Íè¤È¤·¤Æ¡¢¥¢¥ì¥ë¥®¡¼¡¢ÆâʬÈç¡¢·ì±Õ¡¢¿À·Ð¡¢½Û´Ä´ï¡¢Æý»ù·ò¿Ç¡¦¥·¥Ê¥¸¥¹³°Í衦ȯã¥Õ¥©¥í¡¼¥¢¥Ã¥×³°Íè¤ò³«Àߤ·¡¢ÀìÌç°å»Õ¤¬¿ÇÎŤˤ¢¤¿¤Ã¤Æ¤¤¤Þ¤¹¡£

  • ¡¦³ÆÀìÌç³°Íè¡Ê·î¡Á¶â¡¢¸á¸å¡¢´°Á´Í½ÌóÀ©¡Ë
  • ¡¦Æý»ù·ò¿Ç¡Ê½µ2²ó¡¢´°Á´Í½ÌóÀ©¡Ë
  • ¡¦Í½ËÉÀܼï¡Ê·î3²ó¡¢´°Á´Í½ÌóÀ©¡Ë
  • ¡¦¥·¥Ê¥¸¥¹³°Íè¡Ê·î4²ó¡¢´°Á´Í½ÌóÀ©¡Ë
  • ¡¦È¯Ã£¥Õ¥©¥í¡¼¥¢¥Ã¥×³°Íè¡Ê·î3²ó¡¢´°Á´Í½ÌóÀ©¡Ë

»þ´Ö³°¡¦µßµÞ¿ÇÎÅ

Ìë´Ö¤ª¤è¤ÓµÙÆü¤â24»þ´ÖÂбþ¤·¡¢µßµÞ´µ¼Ô¤µ¤ó¤ÎÂбþ¤ËÅö¤¿¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£
¤«¤«¤ê¤Ä¤±´µ¼Ô¤µ¤ó°Ê³°¤Î½é¿Ç¤ÎÊý¤â¾õ¶·¤Ë±þ¤¸¤Æ¿Ç»¡¤¤¤¿¤·¤Þ¤¹¤Î¤Ç¡¢¼õ¿Ç´õ˾¤ÎºÝ¤Ïɱ¡¤Ø¤´°ìÊ󤯤À¤µ¤¤¡£
¤Ê¤ª¡¢¶ÛµÞÂбþÅù¤Ç¤ä¤à¤ò¤¨¤Ê¤¤¾ì¹ç¤Ï¤ª¼õ¤±¤Ç¤­¤Ê¤¤¤³¤È¤â¤¢¤ê¤Þ¤¹¤Î¤Ç¤´Î»¾µ²¼¤µ¤¤¡£

Æþ±¡¿ÇÎÅ

¢¨´¶À÷ËɻߤΤ¿¤áÌ̲ñ¤ò¶Ø»ß¤µ¤»¤Æ¤¤¤¿¤À¤¤¤Æ¤ª¤ê¤Þ¤·¤¿¤¬¡¢ 2023ǯ11·î¤è¤êÌ̲ñÀ©¸Â¤ò´ËÏÂÃפ·¤Þ¤·¤¿

¾®»ù²ÊÀêͭɾ²¿ô¤Ï40¾²¤Ç¤¹¡£´ðËÜŪ¤Ë¤Ï´°Á´´Ç¸îÂÎÀ©¤Ç¡¢¤ª»Ò¤µ¤Þ¤À¤±¤ªÍ¤«¤ê¤·¤Æ¤¤¤Þ¤¹¡£É¾õ¤ä¤´´õ˾¤Ë¤è¤êÉÕ¤­Åº¤¤²Äǽ¤Ê¥Ù¥Ã¥É¤ò5¾²³ÎÊݤ·¤Æ¤ª¤ê¤Þ¤¹¡£
ÁỺ¡¦Äã½ÐÀ¸ÂνŻù(̤½Ï»ù)¤Ê¤É¤Î¿·À¸»ù´ü¤Î¼À´µ¤Ë¤Ä¤¤¤Æ¤Ï¡¢Åö±¡¤Î»ºÉؿͲʤäÃÏ°è¤Î»ºÉؿͲʤÎÀèÀ¸Êý¤ÈÏ¢·È¤·¿·À¸»ù°åÎŤˤ¢¤¿¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£
¿ÇÎŤϼ缣°åÀ©¤Ç¤¢¤ê¡¢´Ç¸î¤Ï¼õ¤±»ý¤ÁÀ©¤È¥Á¡¼¥à¥Ê¡¼¥·¥ó¥°¤òÊ»ÍѤ·¤Æ¤ª¤ê¤Þ¤¹¡£

É¿ÇÏ¢·È ÃÏ°è¤ÎÃæ³Ëɱ¡¤È¤·¤Æ¤Îµ¡Ç½¤ò²Ì¤¿¤¹¤¿¤á¤Ë¸åÊý»Ù±çɱ¡¤È¤·¤Æ¤À¤±¤Ç¤Ï¤Ê¤¯¡¢ÃÏ°è¾®»ù°åÎŤθþ¾å¡¦Ï¢·È¤Î¤¿¤á¡¢Äê´üŪ¤Ë¿Ëྮ»ù²Êº©Ïòñ¤ò³«ºÅ¤·¡¢Ã϶è¤ÎÀèÀ¸Êý¤È¶¦¤ËÊÙ¶¯²ñ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£¤µ¤é¤Ë¡¢ÃÏ°è»Ò°é¤Æ¥Í¥Ã¥È¥ï¡¼¥¯¤Ø¤Î»²²Ã¤ä»Ò°é¤Æ»Ù±ç¤Ë¤Ä¤¤¤Æ¤âÃ϶è°å»Õ²ñ¡¢ÊÝ·ò½ê¤È¤ÎÏ¢·È¤Î¤â¤ÈÀѶËŪ¤Ë¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡£
ǧÄ궵°é»ÜÀß (¼Ò)ÆüËÜ¥¢¥ì¥ë¥®¡¼³Ø²ñǧÄ궵°é»ÜÀߡξ®»ù²Ê¡Ï
ÎáÏ£µÇ¯£´·î£±Æü¤«¤éÎáÏ£±£°Ç¯£³·î£³£±Æü
¹ý¹¾¡¦Ä´ÉÛ»Ô¾®»ù½é´üµßµÞÊ¿Æü½àÌë´Ö¿Ç»¡¼¼
Ê¿Æü¡Ê·î¡Á¶â¡Ë19»þ¡Á22»þ¡Ê¼õÉÕ21»þ30ʬ¡Ë

Åö±¡¤Ç¤Ï¹ý¹¾»Ô¤ÈÄ´ÉۻԤȶ¨ÎϤ·¡¢°å»Õ²ñ¤Þ¤¿¤ÏÅö±¡¾®»ù²Ê°å¤¬¿ÇÎŤò¹Ô¤Ã¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç¡¢¤³¤Á¤é¤â¤´»²¾È¤¯¤À¤µ¤¤¡£

¹ý¹¾¡¦Ä´ÉÛ¾®»ù½é´üµßµÞÊ¿Æü½àÌë´Ö¿Ç

¥¢¥ì¥ë¥®¡¼Âбþ¥Û¥Ã¥È¥é¥¤¥ó

Åö±¡¤Ç¤Ï¡¢Ä´ÉÛ»Ô¤ª¤è¤Ó¹ý¹¾»Ô¤È¶¨ÎϤ·¡¢»ÔÆâ¤Î¾®¡¦Ãæ³Ø¹»¤äÊÝ°é±à¡¦ÍÄÃÕ±à¤Ê¤É¡¢»Ò¤É¤â¤¬ÍøÍѤ¹¤ë»ÜÀߤòÂоݤȤ·¤Æ¡¢»ùƸ¡¦À¸Å̤Υ¢¥ì¥ë¥®¡¼¾É¾õȯ¾É»þ¤ËÂбþ¤¹¤ë¤¿¤á¡¢µßµÞÈÂÁ÷¤Î¼õÆþ¤ìµÚ¤Ó¥¢¥ì¥ë¥®¡¼¾É¾õ¤ÎȽÃÇÅù¤Ë·¸¤ëÁêÃ̤¬¤Ç¤­¤ë»ÅÁȤߤò¹½ÃÛ¤·¤Æ¤¤¤Þ¤¹¡£

¿©Êª¥¢¥ì¥ë¥®¡¼¤Î»Ò¶¡¤¿¤Á¤ò¼é¤ë¤¿¤á¤Î¼è¤êÁȤß

Ä´ÉÛ»Ô¥¦¥§¥Ö¥Ú¡¼¥¸¡Ê2022ǯ3·î¸½ºß¡Ë

¥¢¥ì¥ë¥®¡¼¿ÇÎÅ


Åö²Ê¤Ï2019ǯ2·î¤«¤éÅìµþÅÔ¥¢¥ì¥ë¥®¡¼¼À´µ°åÎÅÀìÌçɱ¡¡Ê¾®»ù²Ê¡Ë¤Ë»ØÄꤵ¤ì¤Æ¤ª¤ê¤Þ¤¹¡£
°ìÈÌŪ¤Ê¥¢¥ì¥ë¥®¡¼¿ÇÎŤ˲䨤ơ¢·Ð¸ýÌȱÖÎÅË¡¡ÊµíÆý¡¢Íñ¡¢¾®Çþ¡¢ÂçƦ¡¢ÊÆ¡¢¤´¤Þ¡Ë¤äÀå²¼ÌȱÖÎÅË¡¡ÊµíÆý¡¢Íñ¡Ë¤Ê¤É¡¢¸¦µæ¥ì¥Ù¥ë¤Î¼£ÎŤâ¹Ô¤Ê¤Ã¤Æ¤ª¤ê¤Þ¤¹¤Î¤Ç´õ˾¤¬¤¢¤ì¤Ð¤´ÁêÃ̤¯¤À¤µ¤¤¡£
°Ê²¼¤Î¥Ú¡¼¥¸¤Ç¤Ï¡¢Åö²Ê¤Î¥¢¥ì¥ë¥®¡¼¿ÇÎŤÎÆÃħ¤Ë¤Ä¤¤¤Æ´ðÁÃŪ¤ÊÆâÍƤâ¸ò¤¨¤Ê¤¬¤é¤´¾Ò²ð¤µ¤»¤Æ¤¤¤¿¤À¤­¤Þ¤¹¡£

¼¹É®¡§Â軰ɱ¡¾®»ù²Ê¥Û¡¼¥à¥Ú¡¼¥¸ÊÔ½¸°Ñ°÷²ñ

¿ÇÎżÂÀÓ


2023ǯ ¾®»ù²ÊÆþ±¡´µ¼ÔÆâÌõ¡ÊÁí¿ô564̾¡Ë

¸¦µæ³èÆ°


Âç³Ø¤Î¸¦µæ¾ðÊó¸ø³«¥Ú¡¼¥¸

¡ãÀÕǤ»ÜÀߤȤ·¤Æ¼Â»Ü¤·¤Æ¤¤¤ë¸¦µæ¡ä

  • ¡¦¾®»ù½Å¾ÉÓé¤Ë¤ª¤±¤ë¿ÇÃǤäµÛÆþ¼êµ»»ØƳ¤Î¸ú²Ì¤ÎÄ´ºº(Åö±¡¤Î¿ÇÎÅÏ¿¤òÍѤ¤¤¿¸åÊý»ëŪ¸¡Æ¤)¡¡2023ǯ¡Á
    ¡¦¥¢¥ì¥ë¥®¡¼´µ¼Ô QOL ¸þ¾å¤Î¤¿¤á¤Î°åÎŽ¾»ö¼Ô¤Î¸úΨŪ°éÀ®¡¡2022ǯ¡Á
    ¡¦½Å¾É¤Î·ÜÍñ¥¢¥ì¥ë¥®¡¼¤òÍ­¤¹¤ë¾®»ù¤òÂоݤȤ·¤¿Àå²¼ÌȱÖÎÅË¡¤Î¥×¥é¥»¥ÜÂоȥé¥ó¥À¥à²½Èæ³Ó»î¸³¡ÊSLEAL study¡Ë¡¡2022ǯ¡Á
    ¡¦½Å¾ÉµíÆý¥¢¥ì¥ë¥®¡¼»ù¤Ø¤Î¾¯Î̷иýÌȱÖÎÅË¡¤Î¸¡Æ¤¡¡2021ǯ¡Á
    ¡¦¥¢¥ì¥ë¥®¡¼Âбþ¥Û¥Ã¥È¥é¥¤¥óÍøÍѼÂÂÖÄɲÃÄ´ºº¡Ê¸åÊý»ëŪ¸¡Æ¤¡Ë¡¡2018ǯ¡Á
    ¡¦µíÆý¥¢¥ì¥ë¥®¡¼ÍÄ»ù¤Ø¤Î·Ð¸ýÌȱÖÎÅˡɸ½à²½¤Ø¸þ¤±¤¿¸¡Æ¤¡ÊORIMA study¡Ë¤ÎĹ´ü¸ú²Ì¡¡2018ǯ¡Á
    ¡¦¿©Êª¥¢¥ì¥ë¥®¡¼´µ¼Ô¤ËÂФ¹¤ë·Ð¸ýÌȱÖÎÅË¡¤ÎÍ­¸úÀ­µÚ¤Ó°ÂÁ´À­¤Ë´Ø¤¹¤ë¸¦µæ¡¡2014ǯ¡Á

¡ã¶¦Æ±¸¦µæ¡Ê¾»ÜÀߤ¬¼Â»Ü¤·¤Æ¤¤¤ë¸¦µæ¤Ë»²²Ã¤·¤Æ¤¤¤ë¤â¤Î¡Ë¡ä

  • ¡¦2022ǯ½ÐÀ¸»ù¤òÂоݤȤ·¤¿¥Ï¥¤¥ê¥¹¥¯¿·À¸»ù°åÎÅÁ´¹ñÄ´ºº¡¡2024ǯ¡Á
    ¡¦¥¢¥Ê¥Õ¥£¥é¥­¥·¡¼¾ÉÎã¤Ë´Ø¤¹¤ë¼ÂÂÖÄ´ºº¡¡2024ǯ¡Á
    ¡¦½Å¾É¡¦Æñ¼£À­¥¢¥ì¥ë¥®¡¼¼À´µ¤Î´µ¼Ô¥ì¥¸¥¹¥È¥ê¤Î¹½ÃÛ¤ª¤è¤ÓÉÂÂÖ²òÌÀ¡¡2024ǯ¡Á
    ¡¦¾®»ù¿¯½±À­ÇÙ±êµå¶Ý´¶À÷¾É´µ¼Ô¤«¤éʬΥ¤µ¤ì¤¿ÇÙ±êµå¶Ý³ô¤Îè²Ëì·ìÀ¶·¿Ê¬ÉÛµÚ¤ÓÌôºÞ´¶¼õÀ­¤Ë´Ø¤¹¤ë¿»ÜÀ߶¦Æ±´Ñ»¡¸¦µæ¡¡2022ǯ¡Á¡¡Ä¹ºêÂç³Øɱ¡
    ¡¦¾®»ù¤«¤é¼ãǯÀ®¿ÍÓé¤Ë¤ª¤±¤ëÀ¸Êª³ØŪÀ½ºÞ»ÈÍѤμÂÂÖÄ´ºº¡¡2022ǯ¡Á¡¡·²ÇÏÂç³Ø°å³ØÉôÉí°É±¡
    ¡¦ÅìµþÅÔ¾®»ù COVID-19 ¤Î±Ö³Ø¤ÈÎ×¾²ÅªÆÃħ¡¡2020ǯ¡Á¡¡ÅìµþÅÔΩ¾®»ùÁí¹ç°åÎÅ¥»¥ó¥¿¡¼
    ¡¦¾®»ùµßµÞ½ÅÆƼÀ´µÅÐÏ¿Ä´ºº¡¡2016ǯ¡Á¡¡ÆüËܾ®»ùµßµÞ°å³Ø²ñ

¸¦µæ¶ÈÀÓ


ºÇ¶á¤Î¼ç¤ÊȯɽÏÀʸ¡ÊÈ´¿è¡Ë

ÏÂʸ

  • £±¡Ë¾¡¾Â½Óͺ¡¥Ê¬ÌîÊÌ»ï¾å¥»¥ß¥Ê¡¼¡¡¥¢¥ì¥ë¥®¡¼¡¥¾®»ù²ÊÎ×¾² 2023: 76; 591-594.
    £²¡ËÀ®À¥È»¿Í¾¡¥ÓéÎà»÷¤Î·Ð²á¸å¤ËÊĺÉÀ­ºÙµ¤´É»Ù±ê¤È¿ÇÃǤ·¤¿1Îã¡¥¾®»ùÆâ²Ê 2023: 55; 885-889.
    £³¡Ë¾¡¾Â½Óͺ¡¥¡Ú¾®»ù¤Î¼£ÎÅÊý¿Ë¡Ûµ¤´É»ÙÓéȯºî¡ÊµÞÀ­Áý°­¡Ë¡¥¾®»ù²Ê¿ÇÎÅ 2023: 86; 254-256.
    £´¡ËÀÄÅÄÌÀ»Ò¾¡¥¥Þ¥«¥À¥ß¥¢¥Ê¥Ã¥Ä¥¢¥ì¥ë¥®¡¼2Îã¤Î¥¢¥ì¥ë¥²¥ó²òÀÏ¡¥Æü¾®¥¢»ï 2023: 37; 99-104.
    £µ¡Ë¾¡¾Â½Óͺ¡¥¾®»ù¤ËÂФ¹¤ë¥¹¥Æ¥í¥¤¥É¤ÎŬÀµ»ÈÍÑ¡¥JOHNS 2023: 39; 373-376.
    £¶¡Ë¾¡¾Â½Óͺ¾¡¥°å»Õ¤ò»Ù¤¨¤ë¿¿¦¼ï¤ÎÎÏ¡¡¥¿¥¹¥¯¥·¥Õ¥È¡ª¥¢¥ì¥ë¥®¡¼¼À´µÎÅÍÜ»ØƳ»Î¡¥Visual Dermatology 2022: 22; 40-43.
    £·¡Ë¾¡¾Â½Óͺ¡¥¥¢¥ì¥ë¥®¡¼¼À´µÎÅÍÜ»ØƳ»Î¡Êlinical Allergy Instructor¡¢CAI¡Ë¡¥¥¢¥ì¥ë¥®¡¼ 2022: 71; 55.
    £¸¡Ë»ûÈøºÌ»Ò¡¢¾¡¾Â½Óͺ¾¡¥µÛÆþ¥¹¥Æ¥í¥¤¥ÉÌô¤ÎÃæ»ß¤Ë¤è¤ê²þÁ±¤·¤¿¤Ó¤Þ¤óÀ­Èƺٵ¤´É»Ù±ê¤Î¾ÉÎã¡¥¾®»ù²Ê¿ÇÎÅ 2022: 85; 387-390.
    £¹¡ËÃÝÆâÇî°ì¾¡¥Æ±°ìȯǮ´ü´ÖÆâ¤Ëȯºî¤ò2²óÈ¿Éü¤·¤¿Ç®À­¤±¤¤¤ì¤ó´µ¼Ô¤Ë¤ª¤±¤ë»êŬ´Ñ»¡´ü´Ö¤Î¸¡Æ¤¡¥ÆüËܾ®»ùµßµÞ°å³Ø²ñ»¨»ï 2021; 20: 7-11.
    £±£°¡Ë¾¡¾Â½Óͺ¾¡¥¾®»ùÓÃ©Ĺ´ü´ÉÍýÌô¥Õ¥ë¥Á¥«¥¾¥ó/¥Û¥ë¥â¥Æ¥í¡¼¥ëÇÛ¹çºÞ¤Î̵ºî°Ù²½Èæ³Ó»î¸³¡¥ÆüËܾ®»ù²Ê³Ø²ñ»¨»ï 2021; 125: 588-598.

±Ñʸ

  • £±¡ËSuzuki R, Katsunuma T et al. Olfactory dysfunction in Japanese children with moderate-to-severe allergic rhinitis. Auris Nasus Larynx. 2023; 50: 904-910.
    £²¡ËIgarashi A, Katsunuma T et al.; Nemolizumab-JP04 Study Group. Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: Results from a phase III, randomised, double-blind, placebo-controlled, multicentre study. Br J Dermatol. 2023. doi: 10.1093/bjd/ljad268.
    £³¡ËSaeki H, Katsunuma T et al. Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021, The Japanese Society of Allergology, The Japanese Dermatology Association. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021. Allergol Int 2022; 71: 448-458.
    £´¡ËSaeki H, Katsunuma T et al. English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. J Dermatol 2022; 49: e315-e375. doi: 10.1111/1346-8138.16527.
    £µ¡ËTurner PJ, Katsunuma T et al. Reproducibility of food challenge to cow's milk: Systematic review with individual participant data meta-analysis. J Allergy Clin Immunol 2022; 150: 1135-1143.
    £¶¡ËSagara N et al. Successful sublingual immunotherapy for severe egg allergy in children: a case report. Allergy Asthma Clin Immunol 2021;17(1): 2. doi: 10.1186/s13223-020-00506-1.
    £·¡ËMaeda M, Katsunuma T et al. Effect of oral immunotherapy in children with milk allergy: the ORIMA study. Allergol Int 2021; 70: 223-228.
    £¸¡ËYanagida N, Katsunuma T et al. Treatment-requiring accidental ingestion and risk factors among nursery children with food allergy. Pediatr Allergy Immunol 2021; 32: 1377-1380.
    £¹¡ËMukae H, Katsunuma T et al. The Japanese respiratory society guidelines for the management of cough and sputum (digest edition). JRS guidelines committee for the management of cough and sputum. Respir Investig 2021; 59: 270-290.

´ØÏ¢¥ê¥ó¥¯


Åìµþ»ü·Ã²ñ°å²ÊÂç³Ø¾®»ù²Ê³Ø¹ÖºÂ